Form 4 - Statement of changes in beneficial ownership of securities:
SEC Accession No. 0001450485-25-000007
Filing Date
2025-12-01
Accepted
2025-12-01 16:09:54
Documents
1
Period of Report
2025-11-26

Document Format Files

Seq Description Document Type Size
1 PRIMARY DOCUMENT primarydocument.html 4  
1 PRIMARY DOCUMENT primarydocument.xml 4 6454
  Complete submission text file 0001450485-25-000007.txt   8162
Mailing Address 480 PLEASANT STREET SUITE C400 WATERTOWN MA 02472
Business Address 480 PLEASANT STREET SUITE C400 WATERTOWN MA 02472 617-926-5000
EyePoint Pharmaceuticals, Inc. (Issuer) CIK: 0001314102 (see all company filings)

EIN.: 262774444 | State of Incorp.: DE | Fiscal Year End: 1231
SIC: 3826 Laboratory Analytical Instruments
(CF Office: 08 Industrial Applications and Services)

Mailing Address CONNAUGHT HOUSE 1 BURLINGTON ROAD DUBLIN 4 Ireland
Business Address
Lurker Nancy (Reporting) CIK: 0001450485 (see all company filings)

Type: 4 | Act: 34 | File No.: 000-51122 | Film No.: 251539732